运动训练在多变性心肌病:随机试验的元分析与试验顺序分析
Vinicius Machado Correia1,2, Vicente Morales Ribeiro3, Rafael Henkes Machado3
1Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil vinicius.correia@hc.fm.usp.br.
Heart (British Cardiac Society)
|November 30, 2025
概括
结构化炼对于轻度多变性心肌病 (HCM) 患者来说是安全的,可以改善身体健康并减少心脏壁厚度. 对高风险个体需要进行进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 运动医学 运动医学
- 运动生理学 运动生理学
背景情况:
- 增高性心肌病变 (HCM) 是年轻人和运动员突然心脏死亡 (SCD) 的首要原因.
- 关于运动在HCM治疗中的作用的现有证据在安全性和有效性方面是不确定的.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估结构化炼干预措施与HCM患者的常规护理.
- 评估运动对HCM功能能力和心脏参数的影响.
主要方法:
- 对四项涉及290名参与者,主要患有轻度,非阻塞性HCM的RCT进行了系统审查.
- 随机效应元分析和试验顺序分析 (TSA) 用于评估疗效和证据稳定性.
- 主要结局是峰值氧气消耗 (pVO2);次要结局包括左心室壁厚度,喷射分数 (LVEF) 和不良事件.
主要成果:
- 结构化的运动显著改善了pVO2 (MD 1.81毫升/千克/分钟),并减少了左心室壁厚度 (MD -0.56毫米) 和BMI.
- 没有观察到LVEF或左心室外流梯度的显著变化.
- 没有报告出现不良事件的增加,例如心律不整,昏迷或SCD.
结论:
- 结构化炼是安全有效的改善功能能力和心脏代谢参数在轻度,非阻塞性HCM.
- 更大的多中心RCT是必要的,以确认高风险HCM表型的发现,并建立最佳的培训准则.
更多相关视频
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Exercise and Cardiovascular Response
3.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Exercise and Cardiac Output
1.8K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888


